文献速递肿瘤 PET/CT

多参数[18F]FDG PET/MRI模型结合肿瘤与对侧健康乳腺影像生物标志物辅助乳腺癌诊断

A multiparametric [18F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-06-13

该前瞻性研究纳入141例乳腺影像异常(BI-RADS 4/5)患者,行多参数[18F]FDG PET/MRI检查,以病理为参考标准。多因素回归模型发现肿瘤强化动力学、肿瘤ADCmean和对侧健康乳腺BPE为独立预测因子,三者联合诊断乳腺癌的AUC达0.98。

要点

  • 肿瘤强化动力学、肿瘤ADCmean和对侧健康乳腺BPE是乳腺癌独立预测因子。
  • 三个显著生物标志物联合诊断乳腺癌的AUC为0.98。
  • 其他影像生物标志物(如SUVmax、FGT)在模型中未达显著性。

核心结论

  • 结合肿瘤和对侧健康乳腺组织定性和定量参数的多参数[18F]FDG PET/MRI诊断模型有助于乳腺癌诊断。

研究设计与样本

  • 前瞻性研究及回顾性数据分析,纳入141例(平均57岁)乳腺钼靶和/或超声发现BI-RADS 4/5异常的患者。
  • 所有患者接受联合多参数[18F]FDG PET/MRI检查,包括PET/CT和3T乳腺多参数MRI。
  • 以组织病理学作为参考标准,进行单因素、双因素和多因素逻辑回归分析,并用ROC曲线下面积(AUC)评估预测判别能力。

主要发现

  • 共100个恶性病变和41个良性病变,病变大小中位数1.9 cm(范围0.5-10 cm)。
  • 多因素回归模型纳入显著单因素预测因子后,确定肿瘤强化动力学(P=0.0003)、肿瘤ADCmean(P<0.001)和对侧健康乳腺BPE(P=0.0019)为乳腺癌诊断的独立预测因子。
  • 其他生物标志物未达到显著性。
  • 三个显著生物标志物联合诊断乳腺癌的AUC值为0.98。

关键数值与推荐

  • 多因素回归模型纳入的独立预测因子:肿瘤强化动力学(P=0.0003)、肿瘤ADCmean(P<0.001)、对侧健康乳腺BPE(P=0.0019)。
  • 三个显著生物标志物联合诊断乳腺癌的AUC值为0.98。

临床怎么用

  • 在BI-RADS 4/5乳腺病变患者中,多参数[18F]FDG PET/MRI模型可整合肿瘤强化动力学、ADCmean和对侧健康乳腺BPE,辅助乳腺癌诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop a multiparametric [18F]FDG positron emission tomography/magnetic resonance imaging (PET/MRI) model for breast cancer diagnosis incorporating imaging biomarkers of breast tumors and contralateral healthy breast tissue. METHODS: In this prospective study and retrospective data analysis, 141 patients (mean 57 years) with an imaging abnormality detected on mammography and/or ultrasound (BI-RADS 4/5) underwent combined multiparametric [18F]FDG PET/MRI with PET/computed tomography and multiparametric MRI of the breast at 3 T. Images were evaluated and the following were recorded: for the tumor, BI-RADS descriptors on dynamic contrast-enhanced (DCE)-MRI, mean apparent diffusion co-efficient (ADCmean) on diffusion-weighted imaging (DWI), and maximum standard uptake value (SUVmax) on [18F]FDG-PET; and for the contralateral healthy breast, background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on DCE-MRI, ADCmean on DWI, and SUVmax. Histopathology served as standard of reference. Uni-, bi-, and multivariate logistic regression analyses were performed to assess the relationships between malignancy and imaging features. Predictive discrimination of benign and malignant breast lesions was examined using area under the receiver operating characteristic curve (AUC). RESULTS: There were 100 malignant and 41 benign lesions (size: median 1.9, range 0.5-10 cm). The multivariate regression model incorporating significant univariate predictors identified tumor enhancement kinetics (P = 0.0003), tumor ADCmean (P < 0.001), and BPE of the contralateral healthy breast (P = 0.0019) as independent predictors for breast cancer diagnosis. Other biomarkers did not reach significance. Combination of the three significant biomarkers achieved an AUC value of 0.98 for breast cancer diagnosis. CONCLUSION: A multiparametric [18F]FDG PET/MRI diagnostic model incorporating both qualitative and quantitative parameters of the tumor and the healthy contralateral tissue aids breast cancer diagnosis.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Leithner D, Horvat JV, Bernard-Davila B, et al. A multiparametric [18F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis. Eur J Nucl Med Mol Imaging. 2019. PMID: 31197455. doi:10.1007/s00259-019-04331-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。